Replies to post #4569 on Avid Bioservices Inc (CDMO)

[cjgaddy]

Katie, what do you think are the chances that the 'appropriate future scientific forum' mentioned in the PR where HepC viral titer data will be released might be one of these?

Apr8-11 2006: “BIO2006 – Annual Intl. Convention”, Chicago
May 12-16 2006: “American Assoc. of Immunologists (AAI) Annual Mtg.”, Boston

Like YoMom pointed out on RB, BIO2005 is where this was announced last year:
“Tarvacin Binds to Viruses in 6 Diff. Virus Families: HIV 1+2, Influenza A+B, Measles, RSV, BVDV (HepC model), and Pichinde. Inhibits Repl. of Multiple Virus Types. Provides significant protection in animals CMV with 100% survival vs. 20% for control animals."

BIO2006 (April 8-11) seems to be the perfect venue to present viral titer data and final safety data for the Godofsky HepC trial. Fingers X'd...

[EZLibra]

More like Most Effective Dose.

"...appears they are close to determining MTD." That is acceptable over MTD now. I don't think toxicity is a concern. In fact lack of toxicity coupled with any decrease in viral load and systemic clearance would make Tarvacin a perfect partner for everything out there.